Ilan Darmon

Honeywell (France)

Papers

1

Total Citations

41

H-Index

1

About

Ilan Darmon is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) and image-guided precision techniques. His most cited work, a 2019 study on fiducial marker implantation for robotic SBRT with fiducial tracking (41 citations), established critical benchmarks for safety and efficacy in treating extracranial tumors. This retrospective, single-centre observational study demonstrated the feasibility of CyberKnife®-guided SBRT, providing foundational evidence for minimizing toxicity while maximizing tumor control. Darmon’s contributions have directly advanced the clinical integration of real-time tumor tracking, enabling more accurate dose delivery to moving targets. His research is widely referenced by clinicians and physicists seeking to optimize SBRT protocols, reflecting its impact on improving patient outcomes in complex anatomical sites. Through rigorous methodology and practical outcomes, Darmon has solidified his reputation as a key contributor to the evolution of non-invasive cancer therapies, bridging technological innovation with tangible clinical benefit.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
41 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Honeywell (France)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago